Your email has been successfully added to our mailing list.

×
0.0227443609022556 0.0225563909774436 0.0150375939849624 0.0150375939849624 0.0150375939849624 0.0150375939849624 0.0338345864661654 0.0263157894736842
Stock impact report

Histogenics Corporation Provides NeoCart® Phase 3 Clinical Trial Enrollment Update

HISTOGENICS CORP COMMON (HSGX) 
Last histogenics corp common earnings: 8/9 04:11 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.histogenics.com
Company Research Source: GlobeNewswire
WALTHAM, Mass., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, announced that as of October 24, 2016 it had enrolled 183, or approximately three-quarters, of the 245 patients required to complete enrollment of its ongoing NeoCart Phase 3 clinical trial.  This trial is being conducted under a Special Protocol Assessment (SPA) with the United States Food and Drug Administration (FDA).  “The enrollment strategies we implemented last year continue to result in increased patient enrollment in our ongoing NeoCart Phase 3 clinical trial.  With enrollment approximately 75% complete and tracking ahead of our expectations, we are now counting down the number of patients required to complete enrollment and turning our focus to the generation and availability of the one-year superiority data and a BLA submission to the FDA shortly thereafter,” Show less Read more
Impact Snapshot
Event Time:
HSGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for HSGX alerts
Opt-in for
HSGX alerts

from News Quantified
Opt-in for
HSGX alerts

from News Quantified